This paper was published through Galoá and has a deposited DOI. To cite this paper, use one of the standards below:
In case you are one of the co-authors and want to register this paper in your Lattes, use the following code: doi > 10.17648/siies-2019-103789
If you've NEVER registered a DOI in your Lattes, check our tutorial!Background: Malignant fungating wounds (MFWs) result from the uncontrolled proliferation of cancerous cells, which cause skin rupture after surrounding tissue infiltration, creating a difficult-to-treat chronic injury. MFWs are present in 5% to 14.5% of cancer patients. They have friable tissue, bleeding easily, highly exudative, odours and also painful. MFW's related pain is explained by the resulting pressure during tumour growing process, the invasion of the skin nerve endings, and finally, the trauma caused by surgical excision and radiotherapy. Additionally, peri-wound dermatitis in high exudate MFWs is severely painful. Additionally, peri-wound dermatitis in high exudate MFWs is severely painful. Literature shows pain prevalence rates from 80.4 to 100% having the patients reporting pain as one of the worst experienced cancer-related symptoms and stating that living with an MFW is devastating. The European Cancer Nursing Society published a guideline with recommendations for the care of patients with MFWs in 2015, highlighting the importance of managing the symptoms, and confirming the lack of evidence in this topic. For this study purposes, a preliminary search was conducted on April 19, 2019, in the Cochrane and The Joanna Briggs Institute (JBI) databases, using the terms "wound" and "pain;" as result, any registered systematic review about the mentioned topic was found so far. Objective: to map the topical therapies used to control pain in MFWs. Review Question: Which topical therapies used to control MFWs’ pain are reported in the literature? Method: This is a scoping review following the JBI methodology.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper